National Guideline Clearinghouse | Denosumab for the prevention of osteoporotic fractures in postmenopausal women.

Guideline Title
National Institute for Health and Clinical Excellence (NICE)
Denosumab for the prevention of osteoporotic fractures in postmenopausal women.

Bibliographic Source(s)
National Institute for Health and Clinical Excellence (NICE). Denosumab for the prevention of osteoporotic fractures in postmenopausal women. London (UK): National Institute for Health and Clinical Excellence (NICE); 2010 Oct. 59 p. (Technology appraisal guidance; no. 204).

Guideline Status
This is the current release of the guideline.

full-text:
National Guideline Clearinghouse | Denosumab for the prevention of osteoporotic fractures in postmenopausal women.